Status:

RECRUITING

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

Lead Sponsor:

Sonya Heltshe

Collaborating Sponsors:

Cystic Fibrosis Foundation

University of Washington

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

Up to 10 years

Brief Summary

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children wit...

Detailed Description

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact in children wit...

Eligibility Criteria

Inclusion

  • Part A:
  • Less than 10 years of age at the first study visit.
  • Documentation of a CF diagnosis.
  • Part B:
  • Participated in Part A OR less than 7 years of age at the first study visit.
  • Documentation of a CF diagnosis.
  • CFTR mutations consistent with FDA labeled indication of highly effective modulator therapy (ivacaftor or elexacaftor/tezacaftor/ivacaftor).
  • Physician intent to prescribe ivacaftor or elexacaftor/tezacaftor/ivacaftor.

Exclusion

  • Part A and Part B:
  • Use of an investigational drug within 28 days prior to and including the first study visit.
  • Use of ivacaftor or elexacaftor/tezacaftor/ivacaftor within the 28 days prior to and including the first study visit.
  • Use of chronic oral corticosteroids within the 28 days prior to and including the first study visit.

Key Trial Info

Start Date :

November 18 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2029

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT04509050

Start Date

November 18 2020

End Date

December 1 2029

Last Update

August 12 2024

Active Locations (35)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (35 locations)

1

The Children's Hospital Alabama, University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233

2

Stanford University Medical Center

Palo Alto, California, United States, 94304

3

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

4

Nemours Children's Clinic

Jacksonville, Florida, United States, 32207

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children | DecenTrialz